{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T08:29:31Z","timestamp":1765268971013},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-024-09866-0","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T13:02:42Z","timestamp":1725886962000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Co-infections and secondary infections amid COVID-19 outbreaks in Vietnam"],"prefix":"10.1186","volume":"24","author":[{"given":"Hong Tham","family":"Pham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thi Ha","family":"Truong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim-Huong","family":"Truong-Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao Khanh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minh-Hoang","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,9]]},"reference":[{"issue":"2","key":"9866_CR1","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jinf.2020.05.046","volume":"81","author":"L Lansbury","year":"2020","unstructured":"Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81(2):266\u201375. https:\/\/doi.org\/10.1016\/j.jinf.2020.05.046.","journal-title":"J Infect"},{"key":"9866_CR2","doi-asserted-by":"publisher","DOI":"10.1590\/s1678-9946202264006","volume":"64","author":"RLD Costa","year":"2022","unstructured":"Costa RLD, Lamas CDC, Simvoulidis LFN, et al. Secondary infections in a cohort of patients with COVID-19 admitted to an intensive care unit: impact of gram-negative bacterial resistance. Rev Inst Med Trop Sao Paulo. 2022;64: e6. https:\/\/doi.org\/10.1590\/s1678-9946202264006.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"1","key":"9866_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12879-022-07192-x","volume":"22","author":"A De Bruyn","year":"2022","unstructured":"De Bruyn A, Verellen S, Bruckers L, et al. Secondary infection in COVID-19 critically ill patients: a retrospective single-center evaluation. BMC Infect Dis. 2022;22(1):207. https:\/\/doi.org\/10.1186\/s12879-022-07192-x.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"9866_CR4","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s13054-021-03672-9","volume":"25","author":"G Grasselli","year":"2021","unstructured":"Grasselli G, Cattaneo E, Florio G. Secondary infections in critically ill patients with COVID-19. Crit Care. 2021;25(1):317. https:\/\/doi.org\/10.1186\/s13054-021-03672-9.","journal-title":"Crit Care"},{"issue":"2","key":"9866_CR5","first-page":"161","volume":"54","author":"KC Lie","year":"2022","unstructured":"Lie KC, Shakinah S, Pasaribu A, Sinto R, Nainggolan L. Observational Study on Secondary Bacterial Infection and the Use of Antibiotics in COVID-19 Patients Treated in a Tertiary Referral Hospital. Acta Med Indones. 2022;54(2):161\u20139.","journal-title":"Acta Med Indones"},{"issue":"6","key":"9866_CR6","doi-asserted-by":"publisher","first-page":"e116","DOI":"10.1016\/j.jinf.2022.03.017","volume":"84","author":"F Murgia","year":"2022","unstructured":"Murgia F, Fiamma M, Serra S, et al. The impact of secondary infections in COVID-19 critically ill patients. J Infect. 2022;84(6):e116\u20137. https:\/\/doi.org\/10.1016\/j.jinf.2022.03.017.","journal-title":"J Infect"},{"issue":"1","key":"9866_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3904\/kjim.2022.084","volume":"38","author":"YS Na","year":"2023","unstructured":"Na YS, Baek AR, Baek MS, et al. Clinical outcomes of and risk factors for secondary infection in patients with severe COVID-19: a multicenter cohort study in South Korea. Korean J Intern Med. 2023;38(1):68\u201379. https:\/\/doi.org\/10.3904\/kjim.2022.084.","journal-title":"Korean J Intern Med"},{"issue":"1","key":"9866_CR8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s15010-021-01661-2","volume":"50","author":"V De Santis","year":"2022","unstructured":"De Santis V, Corona A, Vitale D, et al. Bacterial infections in critically ill patients with SARS-2-COVID-19 infection: results of a prospective observational multicenter study. Infection. 2022;50(1):139\u201348. https:\/\/doi.org\/10.1007\/s15010-021-01661-2.","journal-title":"Infection"},{"issue":"1","key":"9866_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jinf.2022.10.043","volume":"86","author":"S Hu","year":"2023","unstructured":"Hu S, You Y, Zhang S, et al. Multidrug-resistant infection in COVID-19 patients: A meta-analysis. J Infect. 2023;86(1):73\u20135. https:\/\/doi.org\/10.1016\/j.jinf.2022.10.043.","journal-title":"J Infect"},{"issue":"4","key":"9866_CR10","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/aje\/kwm324","volume":"167","author":"S Suissa","year":"2008","unstructured":"Suissa S. Immortal Time Bias in Pharmacoepidemiology. Am J Epidemiol. 2008;167(4):492\u20139. https:\/\/doi.org\/10.1093\/aje\/kwm324.","journal-title":"Am J Epidemiol"},{"key":"9866_CR11","unstructured":"COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Accessed 20 September 2022. Available from: https:\/\/www.covid19treatmentguidelines.nih.gov\/"},{"issue":"3","key":"9866_CR12","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u201381. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x.","journal-title":"Clin Microbiol Infect"},{"key":"9866_CR13","unstructured":"CLSI. Performance standards for antimicrobial susceptibility testing. CLSI supplement M100. 30th ed.\u00a0Pennsylvania, USA: Clinical and Laboratory Standards Institute; 2020."},{"key":"9866_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jclinepi.2022.05.021","volume":"149","author":"A van Zwieten","year":"2022","unstructured":"van Zwieten A, Tennant PWG, Kelly-Irving M, Blyth FM, Teixeira-Pinto A, Khalatbari-Soltani S. Avoiding overadjustment bias in social epidemiology through appropriate covariate selection: a primer. J Clin Epidemiol. 2022;149:127\u201336. https:\/\/doi.org\/10.1016\/j.jclinepi.2022.05.021.","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"9866_CR15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.21037\/atm.2018.02.12","volume":"6","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Reinikainen J, Adeleke KA, Pieterse ME, Groothuis-Oudshoorn CGM. Time-varying covariates and coefficients in Cox regression models. Ann Transl Med. 2018;6(7):121. https:\/\/doi.org\/10.21037\/atm.2018.02.12.","journal-title":"Ann Transl Med."},{"issue":"2","key":"9866_CR16","first-page":"65","volume":"6","author":"S Holm","year":"1979","unstructured":"Holm S. A Simple Sequentially Rejective Multiple Test Procedure. Scand J Stat. 1979;6(2):65\u201370.","journal-title":"Scand J Stat"},{"key":"9866_CR17","unstructured":"World Health Organization, Regional Office for the Western Pacific. The Asia-Pacific perspective: redefining obesity and its treatment. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/206936"},{"issue":"1","key":"9866_CR18","doi-asserted-by":"publisher","first-page":"13345","DOI":"10.1038\/s41598-023-39632-2","volume":"13","author":"B Ka\u00e7maz","year":"2023","unstructured":"Ka\u00e7maz B, Keske \u015e, Si\u015fman U, et al. COVID-19 associated bacterial infections in intensive care unit: a case control study. Sci Rep. 2023;13(1):13345. https:\/\/doi.org\/10.1038\/s41598-023-39632-2.","journal-title":"Sci Rep"},{"key":"9866_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.784130","volume":"12","author":"S Pourajam","year":"2022","unstructured":"Pourajam S, Kalantari E, Talebzadeh H, et al. Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic. Front Cell Infect Microbiol. 2022;12: 784130. https:\/\/doi.org\/10.3389\/fcimb.2022.784130.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"9866_CR20","doi-asserted-by":"publisher","first-page":"12703","DOI":"10.1038\/s41598-021-92220-0","volume":"11","author":"N Shafran","year":"2021","unstructured":"Shafran N, Shafran I, Ben-Zvi H, et al. Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients. Sci Rep. 2021;11(1):12703. https:\/\/doi.org\/10.1038\/s41598-021-92220-0.","journal-title":"Sci Rep"},{"key":"9866_CR21","doi-asserted-by":"publisher","DOI":"10.1017\/s0950268821001254","volume":"149","author":"Q Chen","year":"2021","unstructured":"Chen Q, Li D, Beiersmann C, et al. Risk factors for antibiotic resistance development in healthcare settings in China: a systematic review. Epidemiol Infect. 2021;149: e141. https:\/\/doi.org\/10.1017\/s0950268821001254.","journal-title":"Epidemiol Infect"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09866-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-09866-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09866-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T13:02:53Z","timestamp":1725886973000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-09866-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,9]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9866"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-09866-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,9]]},"assertion":[{"value":"17 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of NDGD Hospital (under approval number 61\u20132021\/NDGD-HDDD) and was conducted in accordance with the Declaration of Helsinki. As only relevant information was collected without revealing the patient\u2019s identity, patient consent was not required, as declared by the Ethics Committee of NDGD Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"HTP reported receiving speaking fees and travel reimbursement from Servier Vietnam Ltd and Pfizer Vietnam Ltd, grants from Servier Vietnam Ltd outside the submitted work. M-HT reported receiving travel reimbursement from Pfizer Vietnam Ltd, speaking fees and grants from Servier Vietnam Ltd outside the submitted work. The remaining authors declare no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"945"}}